Public record of meeting, 4 June 2018

MINUTES

Day 1

1. Welcome and Introductions; Review of Action Summary and Agenda – Brett Thombs

Dr. Thombs welcomed the group to Ottawa and thanked them for their attendance. Dr. Thombs asked everyone to introduce themselves. He then reviewed logistical items and expense forms, which will be sent out after the meeting.

Dr. Thombs noted a few significant accomplishments and changes in the work of the Task Force. Dr. Thombs congratulated Working Groups on recent and forthcoming guideline publications and praised efforts to integrate more bilingualism into Task Force products and outreach. He also noted a recent change in the publication of evidence reviews and protocols, which will now be published in the journal Systematic Reviews.

2. Osteoporosis – Guylène Thériault

Dr. Thériault presented on behalf of the Osteoporosis Working Group. The presentation reviewed the PICOS for Key Question 1 and sought input from Task Force members on Key Questions 3 and 4.

3. Knowledge Translation (KT) Working Group Update – Danica Buckland, Danielle Kasperavicius, Sharon Straus

Ms. Buckland, Ms. Kasperavicius, and Dr. Straus provided an update on behalf of the Knowledge Translation team, reviewing current KT activities underway and inviting Task Force input on the proposed patient reminders project.

4. Prevention PLUS – Eddy Lang, Danica Buckland

Dr. Lang and Ms. Buckland reviewed features of the new Prevention+ site, a literature surveillance platform recently contracted at McMaster University by the Task Force.

5. Depression Update – Eddy Lang

Dr. Lang led an update on behalf of the Depression Screening Guideline Working Group, with a focus on discussion of the protocol, patient values and preferences work, and estimated timelines and next steps.

6. Methods Working Group Update, Part 1 – Brett Thombs

Dr. Thombs led an update on behalf of the Methods Working Group, for continuation on Day 2. With the aim of securing Task Force input and approval, the presentation focused on changes to the analytic frameworks/harms, new approaches to guidelines updates, and the proposed shift in language from “weak” to “conditional” terminology.

7. Breast Cancer Update – Scott Klarenbach

Dr. Klarenbach led an update on behalf of the Breast Cancer Working Group, reviewing progress to-date and next steps as well as the patient knowledge translation tool.

8. H&K Media Updates (IV and ASB updates, BCU discussion) – Jennifer Field, David Rodier

Mr. Rodier and Ms. Field of H&K gave brief updates on media reception for the Impaired Vision and Asymptomatic Bacteriuria Guidelines, and presented on the anticipated media rollout for the Breast Cancer Update.

9. Verbal Updates, Part 1 – Ainsley Moore, Brenda Wilson, Susan Courage

Dr. Moore provided an update on behalf of the Asymptomatic Bacteriuria Working Group, reviewing key promotional dates around the forthcoming publication of the guideline on July 9th, 2018.

Dr. Wilson and Ms. Courage provided an update on behalf of the Impaired Vision Working Group. Published in May 2018, the guideline concluded with a weak recommendation against screening community-dwelling adults (aged 65 and over), based on low-quality evidence and opportunity cost without evidence of benefit. There was limited media reach.

10. Topics Working Group – Brett Thombs

Dr. Thombs than led an update on final topic selection for the coming year. The main goal of the conversation was to discuss ratings and comments and to narrow the selection of topics for scoping and guideline development.